Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells

about

Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin.

P2860

Q36253212-E88665D5-3BE5-4209-BD0C-5806DB15D180 Q37690896-A4B6182F-BE7E-4AAB-8424-B615F3F7F4B2

P2860

Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells

Item

http://www.wikidata.org/entity/Q38958264

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Synergistic antitumor effects ...... atment in gastric cancer cells

@en

type

Item

label

Synergistic antitumor effects ...... atment in gastric cancer cells

@en

prefLabel

Synergistic antitumor effects ...... atment in gastric cancer cells

@en

P1476

Synergistic antitumor effects ...... atment in gastric cancer cells

@en

P2093

Bin Xu

http://www.w3.org/2001/XMLSchema#string

Changping Wu

http://www.w3.org/2001/XMLSchema#string

Jingting Jiang

http://www.w3.org/2001/XMLSchema#string

Jinjin Yuan

http://www.w3.org/2001/XMLSchema#string

Jun Wu

http://www.w3.org/2001/XMLSchema#string

Liangrong Shi

http://www.w3.org/2001/XMLSchema#string

Mei Ji

http://www.w3.org/2001/XMLSchema#string

Zhengguang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Resistance mechanisms following cisplatin and oxaliplatin treatment of the human teratocarcinoma cell line 2102EP.

Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: report from the Japan Clinical Oncology Group (JCOG).

The role of chemotherapy in metastatic gastric cancer.

Performance of different gastric cancer screening methods in Korea: a population-based study.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer.

P304

1603-1607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2014.2368

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265472347

http://www.w3.org/2001/XMLSchema#string

P698

25202376

http://www.w3.org/2001/XMLSchema#string

P932

4156208

http://www.w3.org/2001/XMLSchema#string

Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells

about

P2860

P2860

Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932